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balloon to prevent cerebral emboli. Six symptomatic patients had 7 PTAs (6
carotids, 1 vertebral).
Pt. # Angioplasty Transcrania Stenosis Complications Stenosis
Technique Doppler Pre~Post 3 m F/U
1 Protected 73 emboli 90%--.20% none 10%
2 Protected 40 emboli 90%~ 0% none 0%
3 Active Perf. no window 95%~O% none 0%
4 Active Perf. 10 emboli 99%---+0% none 0%
5 Active Perf. no window 99%--+0% hemorrh--.death
6 Standard no window 100%-+30%-+ none pendin9
(vertebral) 5tent-+0%
Active Perf. 70%--)o-dissec, none pending
(carotid) 20%-+ 5tent--+ 0%
Maintenance of cerebral perfusion during PTA by "active" perfusion and
cardiac pacing allows prolonged balloon inflations which minimize residual
stenosis; when feasible, TCD monitoring is a valuable adjunct. Ongoing stud-
ies with more patients will elucidate the value of this approach for carotid
angioplasty.
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Treatment of Superficial Femoral Artery Occlusion by
Percutaneous Revascularizatlon of Ipsilateral Iliac
Artery Stenosis
Waqar Khan, Robert Schainfeld, Ann Pieczek, Kenneth Rosenfield, Jeffrey M. Isner.
St. Elizabeth's Medical Center, Boston, MA Tufts University School of Medicine, Boston,
MA
Systolic Blood Pressure
N Baseline 24 hr 1 mo 6 mo
Total cohort 39 177 ± 22 138 ± 20* 158 ± 30** 152 ± 25*
Responders (R) 25 184 ± 22 140 ± 23* 160 ± 32* 143 ± 21*
Non-responders (NR) 14 166 ± 19 134± 11* 157 ± 30 167 ± 25
*p < 0.0001, **p < 0.001 versus baseline BP
A significant (:::15%) improvement in SBP and/or DBP was measured in
86% of all patients 24 hours after stent implantation. At one and 6 months,
63% had sustained improvement in both SBP and DBP and were long-term
responders. A sustained BP improvement 6 months after stenting was pre-
dicted by older patient age, more severe hypertension, and larger reference
vessel diameter (p < 0.05). Not predictive of a favorable response to stent-
ing was sex, number of HTN medications, unilateral versus bilateral disease,
baseline serum Cr, BUN, or 6 month angiographic (:::50% diameter) resteno-
sis.
Conclusion: Renal artery stenting results in immediate BP control in the
majority patients studied, however, this BP improvement is sustained in only
63% of patients. Multi-variant analysis indicates that older patients with more
severe hypertension and larger renal arteries are more likely to receive a sus-
tained benefit from renal artery stenting.
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Tanvir K. Bajwa, Yoseph Shalev, Donald H. Schmidt University of Wisconsin,
Milwaukee, WI
*p < 0.05; values listed are pre- and 12 months post-procedure
No RestenosisBilateralUnilateral
Central vein occlusion is a common cause of morbidity in patients with up-
per extremity hemodialysis (HD) access sites and a history of ipsilateral in-
dwelling central lines. We analyzed the results of two percutaneous treat-
ments, balloon angioplasty (PTA) and stenting (S) that were used to relieve
symptomatic venous occlusion (arm edema, pain) and improve dialysis effi-
ciency (venous pressure and recirculation fraction). Group I consisted of 26
patients (13 men, 13 women, mean age ~ 62 ± 14.3), with de novo lesions
(innominate = 5, subclavian = 21) who underwent PTA. Group II consisted of
13 patients from Group I who underwent stent implantation (6 Palmaz stents,
7 Wallstents) for failed PTA due to suboptimal angioplasty results (n = 5) or
restenosis In = 8). We retrospectively compared the acute and long-term
clinical success and restenosis rates in these two treatment groups. Acute
success was defined as resolution of symptoms and resumption of dialy-
sis. Restenosis was defined as >50% stenosis by angiography. Long-term
success @ mean follow-up 14 months was defined as continued dialysis
without symptomatic venous occlusion or dialysis graft failure.
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Comparison of Stenting and PTA for Central Venous
Stenosis In Hemodialysis Patients
Peter Wassmer, Shabblr Dharamsey, Reynaldo Mulingtapang, SylVia Griffin,
Sam Money, Stephen Jenkins, Christopher White, Stephen Ramee. Ochsner Clinic,
New Orleans. LA; Health Care International, Glasgow, Scotland
Complications: Two patients developed pseudoaneurysm of left brachial
artery, which required percutaneous closure.
Conclusions: 1) Renal artery stenting can be performed with a low com-
plication rate, 2) In the majority of patients, symptomatic improvement was
achieved and maintained over a 12-month period and the number of antihy-
pertensive medications required decreased, and 3) Based on our study, we
would recommend renal artery stenting as the therapeutic option of choice
for symptomatic renal artery stenosis.
Creatinine (mg%) 2.1 ± 1.1 to 15 ± 0.9 2.5 ± 0.7 to 1.5 ± 0.6 2.1 ± 0.6 to 1.5
Diastolic BP ImmHg) 95 ± 10 to 80± S* 9O± 9 to SO ± 5* 90±7 to SO± 2*
No. of Meds. 3.2 ± 1to 1.1 ± 09* 2.9 ± 1 to 20 ± 0.5* 3.1 ± 1to 1.5 ± 1.0'
Palmaz-Schatz stents were deployed in 55 renal arteries (articulated in 30 and
nonarticulated in 25) of 45 pts (35 unilateral. 10 bilateral). Forty of the patients
were male and 5 were female (mean age 65 ± 5 years). 20/45 (44%) pts had
associated diabetes mellitus and coronary artery disease. We retrospectively
analyzed clinical outcome (renal functions, blood pressure, and number of
antihypertensive medications) at 6 and 12 months. Six month angiographic
followup was available in 25/45 pts (56%) and showed a restenosis rate of
5/25 (20%).
To evaluate the acute and chronic blood pressure (BP) response after renal
artery stent implantation, we prospectively studied 39 patients (14 men, 25
women, mean age = 67 ± 1O) with hypertension IHTN) refractory to medical
therapy and atherosclerotic renal artery stenosis I:::70%) who were treated
with balloon angioplasty and deployment of a stainless steel, non-articulated,
balloon expandable Palmaz stent. Twenty three (59%) patients had unilateral
stenosis, 14 (36%) had bilateral disease, and 2 (5%) had a solitary kidney. The
mean number of anti-hypertensive medications was 2.5 before treatment.
BP was recorded at baseline, 24 hrs., and at 1, 3, and 6 months after stent
implantation. Patients were classified either as responders (R), defined as
a ::: 15% drop in systolic (SBP) and/or diastolic blood pressure (DBP) from
baseline Bp, or non-responders (NR) based on their 6 month BP result.
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Acute and Long-term Effect of Renal Artery Stentlng
on Blood Pressure Control In Patients with
Atherosclerotic Renovascular Hypertension
Dinesh Shaw, Christopher White, Tyrone Collins, Arun Karsan, Melissa Facundus,
Richard Milani, Stephen Ramee. Ochsner Clinic, New Orleans; Health Care
International, Glasgow, Scotland
The acute and long-term results of percutaneous revascularization of the
lower extremities are typically superior for inflow (iliac) than distal (super-
ficial femoral artery SFA, popliteal, or infrapopliteal disease). Accordingly, we
investigated the utility of performing percutaneous revascularization for only
inflow (iliac) lesions in pts with both inflow as well as distal disease. We
treated 43 limbs in 36 pts (28 M, 8 F, age mean ± SD = 69 ± 8 yrs) with
the combination of SFA occlusion and ipsilateral iliac artery lesions by percu-
taneous revascularization of the iliac artery lesion only. Ten lesions involved
the common iliac artery, 18 involved both the common and the external iliac
arteries, and 15 consisted of external iliac artery stenosis. All pts were symp-
tomatically Rutherford class 3 and/or above. Mean ankle-brachial index (ABI)
pre-procedure was 0.55 ± 0.19. Ipsilateral iliac artery stenosis, determined
by quantitative angiography, was 80 ± 12%. All iliac lesions were treated
with percutaneous transluminal angioplasty (PTA) ± stent placement. Post-
PTA, iliac artery stenosis decreased to 8 ± 8%. Of the 43 treated limbs, 40
(93%) were associated with improvement by at least one Rutherford class.
One month post-procedure, mean ABI improved to 0.63 ± 0.191p < 0.009).
Complications were limited to 1 instance of arterial dissection which was
successfully treated with a stent. Six-month follow-up was available on 24/43
limbs; 19/24 (79%) continued to show improved symptoms measured by
Rutherford class. ABI's were remeasured at six months in 22 pts, and 18/22
(82%) showed improved ABI compared to baseline. Conclusion: Percuta-
neous revascularization limited to iliac artery stenosis in patients with ipsilat-
eral superficial femoral artery occlusion, by augmenting arterial inflow via a
patent profunda, is frequently sufficie'1t to produce clinical improvement of
disabling symptoms.
